14.3 Donor hematopoietic cell expression of PD-L1 is required for prevention of split tolerance in MHC-mismatched mixed chimeras
Ms. Yaxun Huang, United States
14.4 Anti-HLA-I antibody stimulates glomerular endothelial cells to increase galectin-1 protein secretion via ERK
Mr. Alex Boshart, Canada
14.5 The role of LAG3 in antibody responses to kidney transplantation
Dr. Michael Nicosia, United States
14.6 Beneficial Effects of C1q in Resolving Ischemia Reperfusion in Kidney Transplants
Dr. Hirotsugu Noguchi, United States
14.7 Protein and miRNA expression distinguish DSA+ kidney transplant recipients with and without antibody-mediated rejection
Dr. Kieran Manion, Canada
14.8 CD38 activation with methionine choline deficient (MCD) diet-induced liver injury in rats
Dr. Jung Lye Kim, United States
14.9 Anti-apoptosis and necrosis effect of Necrostatin-1 in skin and muscle cell lines subjected to prolonged cold storage and rewarming: Implications for vascularized composite allograft preservation
Dr. Christene A Huang, United States
14.10 Development of an MHC Class II-specific CAR for the modulation of alloreactivity in mice